FDA Warns Boehringer About Misleading Mirapex Ads
German pharmaceutical company Boehringer Ingelheim GmbH misled consumers and doctors about the safety and efficacy of Mirapex, the restless-leg syndrome treatment, according to the U.S. Food and Drug Administration....To view the full article, register now.
Already a subscriber? Click here to view full article